Brief: Galera Announces Updated Data From Its Randomized, Multicenter, Placebo-Controlled Trial In Patients With Pancreatic Cancer

Galera Therapeutics

28/04/2021 22:24

April 28 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES UPDATED DATA FROM ITS RANDOMIZED,
MULTICENTER,
PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH PANCREATIC CANCER
    * GALERA THERAPEUTICS INC - NEAR DOUBLE MEDIAN OVERALL
SURVIVAL
OBSERVED IN PATIENTS RECEIVING GALERA'S DISMUTASE MIMETIC + SBRT
VERSUS PLACEBO + SBRT
    * GALERA THERAPEUTICS INC - IMPROVEMENTS VERSUS PLACEBO ALSO
OBSERVED IN LOCAL TUMOR CONTROL, TIME TO METASTASES AND
PROGRESSION-FREE SURVIVAL
    * GALERA THERAPEUTICS INC - DATA SUPPORT COMPANY'S 160
PATIENT
PHASE 2B PANCREATIC CANCER TRIAL, GRECO-2

Source text for Eikon:  ID:nGNX3J0hWV 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))